Luca Issi
Stock Analyst at RBC Capital
(3.26)
# 3,503
Out of 4,829 analysts
202
Total ratings
45.24%
Success rate
0.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Maintains: Sector Perform | $21 → $18 | $17.52 | +2.74% | 7 | May 8, 2025 | |
| MRNA Moderna | Maintains: Sector Perform | $32 → $28 | $25.70 | +8.95% | 14 | May 2, 2025 | |
| ASND Ascendis Pharma | Maintains: Outperform | $205 → $210 | $154.43 | +35.98% | 2 | May 2, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Sector Perform | $10 → $5 | $2.71 | +84.50% | 7 | Apr 16, 2025 | |
| LXEO Lexeo Therapeutics | Maintains: Outperform | $24 → $20 | $2.63 | +660.46% | 5 | Mar 25, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $310 → $330 | $270.19 | +22.14% | 27 | Mar 21, 2025 | |
| KRRO Korro Bio | Maintains: Outperform | $105 → $95 | $15.98 | +494.49% | 7 | Mar 19, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Sector Perform | $2 | $0.75 | +167.81% | 6 | Mar 18, 2025 | |
| OCUL Ocular Therapeutix | Initiates: Outperform | $17 | $7.39 | +130.20% | 1 | Mar 18, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Outperform | $11 → $13 | $5.62 | +131.32% | 6 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $1.17 | +754.70% | 8 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $15 | $4.35 | +244.83% | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $35 | $3.32 | +954.22% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $26 | $18.24 | +42.54% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $33.53 | +108.77% | 8 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $61.37 | +14.06% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $53 → $48 | $37.59 | +27.69% | 13 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $42 | $13.97 | +200.64% | 8 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $24 | $13.15 | +82.51% | 6 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $57 | $35.85 | +59.00% | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $30 | $7.97 | +276.41% | 9 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $67 | $29.33 | +128.44% | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $45 | $12.56 | +258.28% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $1.54 | +159.74% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $80 | $3.29 | +2,331.61% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $77 | $36.09 | +113.36% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $15 | $6.60 | +127.27% | 5 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $54 | $8.55 | +531.58% | 4 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $0.82 | +1,611.28% | 5 | Aug 7, 2024 |
Apellis Pharmaceuticals
May 8, 2025
Maintains: Sector Perform
Price Target: $21 → $18
Current: $17.52
Upside: +2.74%
Moderna
May 2, 2025
Maintains: Sector Perform
Price Target: $32 → $28
Current: $25.70
Upside: +8.95%
Ascendis Pharma
May 2, 2025
Maintains: Outperform
Price Target: $205 → $210
Current: $154.43
Upside: +35.98%
Adverum Biotechnologies
Apr 16, 2025
Maintains: Sector Perform
Price Target: $10 → $5
Current: $2.71
Upside: +84.50%
Lexeo Therapeutics
Mar 25, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $2.63
Upside: +660.46%
Alnylam Pharmaceuticals
Mar 21, 2025
Maintains: Outperform
Price Target: $310 → $330
Current: $270.19
Upside: +22.14%
Korro Bio
Mar 19, 2025
Maintains: Outperform
Price Target: $105 → $95
Current: $15.98
Upside: +494.49%
Sangamo Therapeutics
Mar 18, 2025
Reiterates: Sector Perform
Price Target: $2
Current: $0.75
Upside: +167.81%
Ocular Therapeutix
Mar 18, 2025
Initiates: Outperform
Price Target: $17
Current: $7.39
Upside: +130.20%
MeiraGTx Holdings
Mar 17, 2025
Maintains: Outperform
Price Target: $11 → $13
Current: $5.62
Upside: +131.32%
Mar 14, 2025
Reiterates: Outperform
Price Target: $10
Current: $1.17
Upside: +754.70%
Mar 4, 2025
Maintains: Outperform
Price Target: $17 → $15
Current: $4.35
Upside: +244.83%
Mar 3, 2025
Maintains: Outperform
Price Target: $39 → $35
Current: $3.32
Upside: +954.22%
Feb 26, 2025
Maintains: Sector Perform
Price Target: $24 → $26
Current: $18.24
Upside: +42.54%
Feb 20, 2025
Reiterates: Outperform
Price Target: $70
Current: $33.53
Upside: +108.77%
Feb 20, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $61.37
Upside: +14.06%
Feb 12, 2025
Maintains: Sector Perform
Price Target: $53 → $48
Current: $37.59
Upside: +27.69%
Feb 11, 2025
Reiterates: Outperform
Price Target: $42
Current: $13.97
Upside: +200.64%
Jan 21, 2025
Reiterates: Outperform
Price Target: $24
Current: $13.15
Upside: +82.51%
Jan 21, 2025
Reiterates: Outperform
Price Target: $57
Current: $35.85
Upside: +59.00%
Jan 21, 2025
Reiterates: Outperform
Price Target: $30
Current: $7.97
Upside: +276.41%
Jan 21, 2025
Reiterates: Outperform
Price Target: $67
Current: $29.33
Upside: +128.44%
Jan 14, 2025
Reiterates: Outperform
Price Target: $45
Current: $12.56
Upside: +258.28%
Dec 13, 2024
Maintains: Sector Perform
Price Target: $5 → $4
Current: $1.54
Upside: +159.74%
Nov 15, 2024
Reiterates: Sector Perform
Price Target: $80
Current: $3.29
Upside: +2,331.61%
Nov 6, 2024
Reiterates: Outperform
Price Target: $77
Current: $36.09
Upside: +113.36%
Oct 21, 2024
Maintains: Sector Perform
Price Target: $7 → $15
Current: $6.60
Upside: +127.27%
Sep 19, 2024
Reiterates: Outperform
Price Target: $54
Current: $8.55
Upside: +531.58%
Aug 7, 2024
Reiterates: Outperform
Price Target: $14
Current: $0.82
Upside: +1,611.28%